Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. MD Anderson Cancer Center at Cooper

Verified

Basic Information

Site Overview

Source: Human-provided.

Cooper University Health Care is a leading academic health system based in Camden, New Jersey, providing comprehensive primary, specialty, tertiary, and urgent care services through three hospitals, more than 130 outpatient locations, and a network of over 1,000 physicians across 95+ specialties. As the primary teaching affiliate of Cooper Medical School of Rowan University, Cooper integrates patient care, medical education, and research to advance innovative healthcare solutions. The organization conducts extensive clinical research and actively participates in Phase I–IV clinical trials across oncology, neurology, cardiology, stroke, surgery, women’s health, and other therapeutic areas. Its research infrastructure supports translational and investigator-led studies, with access to diverse patient populations and specialized centers such as the MD Anderson Cancer Center at Cooper. Cooper is recognized as South Jersey’s leading academic health system, treating more than 2.5 million…

Source: Trial-derived.
36Total Trials
Source: Trial-derived.
7Recruiting Trials
Source: Trial-derived.
18Active Trials
Source: Trial-derived.
10Completed Trials
Source: Trial-derived.
72Unique Conditions
Source: Trial-derived.
43Unique Sponsors

Conditions

Source: Trial-derived. Fallopian Tube Cancer (6)Source: Trial-derived. Ovarian Cancer (4)Source: Trial-derived. Cervical Cancer (3)Source: Trial-derived. Epithelial Ovarian Cancer (3)Source: Trial-derived. Metastatic Melanoma (3)Source: Trial-derived. Complete Response (2)Source: Trial-derived. FIGO Stage III-IV (2)Source: Trial-derived. Newly Diagnosed (2)

Sponsors

Source: Trial-derived. AbbVie (6)Source: Trial-derived. Genmab (4)Source: Trial-derived. Gynecologic Oncology Group (4)Source: Trial-derived. Iovance Biotherapeutics, Inc. (4)Source: Trial-derived. European Network of Gynaecological Oncological Trial Groups (ENGOT) (3)Source: Trial-derived. Merck Sharp & Dohme LLC (3)Source: Trial-derived. Bayer (2)Source: Trial-derived. GOG Foundation (2)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. PET-CT

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Minimal residual disease (MRD) assessment
Source: AI-inferred. PD-L1 tumour biomarker testing
Source: AI-inferred. Serial radiological tumour imaging